
AIRNA
AIRNA is a biotech company developing RNA editing therapeutics for rare and common diseases. It has raised $245M and employs 85 people.
The growth story

AIRNA grew from 3 to 85 employees between 2021 and 2026, raising $245M along the way, most recently a Series B in April 2025.
About
AIRNA creates RNA-based treatments using its RESTORE+ platform, targeting both rare and widespread diseases. The company focuses on advancing a pipeline of therapies through this technology.
Founded in 2021, AIRNA has grown to 85 employees and secured $245M in funding, including a Series B round in April 2025. Its investor base includes ARCH Venture Partners and Forbion Capital Partners.
Founders and leadership
AIRNA’s largest function is Research, with 23 employees. The company is led by a team with experience in biotech and RNA therapeutics.












The AIRNA org chart
Todd Bazemore (Chief Executive Officer) leads 34 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew

Headcount by function: Research 38 (+6% YoY), Business Development 18 (+6% YoY), Legal 4 (+33% YoY).
Talent flow
AIRNA’s team includes former employees of CRISPR Therapeutics, Novartis, and Biogen. Alumni have moved to companies like Prime Medicine and Vivtex.

Most common previous employers of AIRNA staff: CRISPR Therapeutics (4), Novartis (4), University of Tübingen (4), Biogen (3), Akouos (3), Momenta Pharmaceuticals (3). Former AIRNA employees most often moved to Prime Medicine (1), Forbion (1), NewCo (1), Vivtex (1), Vico Therapeutics (1), Dolby Family Ventures (1).
Alumni worth knowing
Web traffic

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of

Most common skills at AIRNA: Biotechnology (26), Molecular Biology (26), Cell Culture (22), Life Sciences (22), Biochemistry (21), Cell Biology (19), Research Skills (19), Leadership (18).
Where the team actually sits

AIRNA people are concentrated in Massachusetts, United States (22), Greater Boston (14), Baden-Württemberg, Germany (14), United Kingdom (2).
Search footprint
AIRNA attracts about 99 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 22 ranking keywords and lost 30 in the last period.
Frequently asked
AIRNA has 85 employees as of September 2026.
AIRNA has raised $245M in total, most recently a Series B round in April 2025.
AIRNA was founded in 2021 by Thorsten Stafforst, Jin Billy Li.
Todd Bazemore (Chief Executive Officer) sits at the top of AIRNA's reporting structure, with 6 direct reports.
The most common previous employers of current AIRNA staff are CRISPR Therapeutics (4 people), Novartis (4 people), University of Tübingen (4 people).
Former AIRNA employees most often move to Prime Medicine (1), Forbion (1), NewCo (1).
AIRNA attracts about 99 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among AIRNA staff are Biotechnology, Molecular Biology, Cell Culture, Life Sciences, Biochemistry.
AIRNA staff are concentrated in Massachusetts, United States (22), Greater Boston (14), Baden-Württemberg, Germany (14).
AIRNA has about 38 people in Research, up 6% over the past year, as of September 2026.
AIRNA has about 18 people in Business Development, up 6% over the past year, as of September 2026.
Computed from 59 current and 18 former AIRNA profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.



